Brought to you by 
Genzyme Surgical, Tissue Repair, and Biomatrix merge
03 Mar 2016
Executive Summary
Two of Genzyme Corp.'s public subsidiaries, Genzyme Tissue Repair and Genzyme Surgical Products will merge with Biomatrix to form a new Genzyme tracking stock, Genzyme Biosurgery.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Medical Devices
- Biomaterials
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Intra-Biotech Deal
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Genzyme Surgical, Tissue Repair, and Biomatrix merge
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice